ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Melanoma and other Skin Tumours
Latest ESMO videos
Featured medwireNews
Stage III High-Risk Melanoma Benefits With Dabrafenib–Trametinib, Pembrolizumab
Continuous BRAF–MEK inhibition Best For BRAF-Mutated Melanoma
Immune-Related Adverse Event Risks Differ By ICI Regimen in Advanced Melanoma
COMBI-AD Biomarker Analysis May Help Guide Stage III Melanoma Care
Cemiplimab Active, Well Tolerated For Locally Advanced Cutaneous SCC
E-Learning
ESMO V-Learning: BRAF Mutations Across Cancers
ESMO E-Learning: New Treatments in Melanoma
ESMO V-Learning: Inhibition of MEK to Treat Cancer, focussing on Melanoma
Factsheets on Biomarkers
PD-L1 in Cancer: ESMO Biomarker Factsheet
NRAS in Melanoma: ESMO Biomarker Factsheet
BRAF in Melanoma: ESMO Biomarker Factsheet
Meeting resources
Melanoma: Immune Checkpoints and Combination therapies
Presenter: J.Haanen, NL
Session: Session 2 - Clinical development
Resources:
Slides
Webcast
The role of B-cells and tertiary lymphoid structures in response to immune checkpoint inhibitors
Presenter: Göran Jönsson
Session: B-cell biology
Resources:
Slides
Webcast
64MO - A phase (ph) II, multi-center study of the safety and efficacy of tebentafusp (tebe) (IMCgp100) in patients (pts) with metastatic uveal melanoma (mUM)
Presenter: Joseph Sacco
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
Loco-regional vs. systemic biomarkers upon local/intratumoural immune checkpoint blockade
Presenter: Tanja de Gruijl
Session: Compartmental biomarker analysis and the management of IO therapy
Resources:
Slides
Webcast
Cancer vaccine triggers antiviral-type defences
Presenter: I. Jolanda M. de Vries
Session: Immunological memory and trained immunity
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.